Systemic Opioid Weaning and Low Dose Intrathecal Morphine Monotherapy for Chronic Nonmalignant Pain

Neuromodulation: Technology at the Neural Interface(2022)

Cited 0|Views3
No score
Abstract
Low Dose Intrathecal Morphine Monotherapy (LDITM) following systemic opioid weaning has been described to be effective in the management of Chronic Nonmalignant Pain (NMP). However, broader multicenter evidence is limited. Here, we report the ongoing Embrace TDD study evaluating pain control and opioid side effects after a change from systemic opioids to LDITM in patients with NMP administered via an implanted drug delivery system.
More
Translated text
Key words
systemic opioid weaning,morphine,chronic nonmalignant pain
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined